Skip to main content
. 2020 Apr 12;12(4):954. doi: 10.3390/cancers12040954
BRAF Serine/threonine-protein kinase B-raf (rapidly accelerated fibrosarcoma)
cfDNA Cell-free DNA
CK-18 Cytokeratin 18
CT Computer tomography
ctDNA Circulating tumor DNA
CTx Platinum-based chemotherapy
ECOG Eastern Cooperative Oncology Performance Status Scale
EGFR Epidermal growth factor receptor
EML4-ALK Echinoderm microtubule associated protein-like 4-anaplastic lymphoma kinase
GSH Glutathione
M30 Caspase-cleaved cytokeratin 18
M65 Full-length cytokeratin 18
miRNA MicroRNA
MRI Magnetic resonance imaging
NOS Non other specified
NSCLC Non-small cell lung cancer
oxGSH Oxidized glutathione
PD Progressive disease
PDL1 Programmed death ligand 1
PR Partial remission
RECIST-1.1 Response Evaluation Criteria in Solid Tumors, version 1.1
SD Stable disease
TKI Tyrosine-kinase-inhibitor